CAD 0.01
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - |
Operating Expenses | 2.32 Million | 2.92 Million | 1.36 Million | 445.96 Thousand | 169.42 Thousand | 955.76 Thousand |
Selling, General and Administrative Expenses | 2.32 Million | 548.05 Thousand | 725.57 Thousand | 180.63 Thousand | 119.72 Thousand | 340.99 Thousand |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | 32.24 Thousand | 66.85 Thousand | 49 Thousand | - | - |
Cost and Expenses | 2.32 Million | 2.92 Million | 1.36 Million | 445.96 Thousand | 169.42 Thousand | 955.76 Thousand |
Operating Income | -2.32 Million | -2.89 Million | -1.3 Million | -396.96 Thousand | -169.42 Thousand | -955.76 Thousand |
Interest Expense | - | 1720.00 | 17.23 Thousand | 25.56 Thousand | 22.49 Thousand | 18.94 Thousand |
Income Tax Expense | - | 33.94 Thousand | 84.03 Thousand | 74.51 Thousand | -113.45 | -161.14 Thousand |
Earnings before Tax | -2.34 Million | -2.9 Million | -1.31 Million | -447.03 Thousand | -191.92 Thousand | -974.7 Thousand |
Net Income | -2.34 Million | -2.9 Million | -1.31 Million | -447.03 Thousand | -191.92 Thousand | -974.7 Thousand |
Earnings Per Share Basic | -0.01 | -0.01 | -0.01 | -0.00 | -0.00 | -0.01 |
Earnings Per Share Diluted | -0.01 | -0.01 | -0.01 | -0.00 | -0.00 | -0.01 |
Weighted Average Shares Outstanding | 234.68 Million | 203.52 Million | 164.07 Million | 142.34 Million | 121.06 Million | 116.18 Million |
Weighted Average Shares Outstanding (Diluted) | 234.68 Million | 203.52 Million | 164.07 Million | 142.34 Million | 121.06 Million | 116.18 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -2.3 Million | -2.89 Million | -1.3 Million | -377.12 Thousand | -169.42 Thousand | -955.76 Thousand |
Earnings Before Tax Margin | - | - | - | - | - | - |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - |
Operating Expenses | 172.81 Thousand | 833.52 Thousand | 380.23 Thousand | 342.81 Thousand | 2.51 Million | 467.39 Thousand |
Selling, General and Administrative Expenses | 16.11 Thousand | 833.52 Thousand | 380.23 Thousand | 342.81 Thousand | - | 38.37 Thousand |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 156.7 Thousand | - | 39.56 Thousand | - | - | - |
Cost and Expenses | 172.81 Thousand | 833.52 Thousand | 380.23 Thousand | 342.81 Thousand | 2.51 Million | 467.39 Thousand |
Operating Income | -172.81 Thousand | -833.52 Thousand | -380.24 Thousand | -342.82 Thousand | -2.51 Million | -467.39 Thousand |
Interest Expense | 47.00 | - | - | - | - | - |
Income Tax Expense | -172.37 Thousand | - | -307.51 | -4.13 | -16.50 | -4.13 |
Earnings before Tax | -172.42 Thousand | -780.85 Thousand | -339.84 Thousand | -344.95 Thousand | -2.34 Million | -465.51 Thousand |
Net Income | -172.42 Thousand | -780.85 Thousand | -339.84 Thousand | -344.95 Thousand | -2.34 Million | -465.51 Thousand |
Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | -0.00 | - | -0.00 |
Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | -0.00 | - | -0.00 |
Weighted Average Shares Outstanding | 270.5 Million | 270.44 Million | 241.16 Million | 236.63 Million | 234.68 Million | 236.63 Million |
Weighted Average Shares Outstanding (Diluted) | 270.5 Million | 270.44 Million | 241.16 Million | 236.63 Million | 234.68 Million | 236.63 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -172.37 Thousand | -833.52 Thousand | -380.24 Thousand | -342.82 Thousand | - | -467.39 Thousand |
Earnings Before Tax Margin | - | - | - | - | - | - |
KPN
NATCOPHARM
BMET
TOY
LN
NVMI